IE792462L - Azetidinones. - Google Patents

Azetidinones.

Info

Publication number
IE792462L
IE792462L IE792462A IE246279A IE792462L IE 792462 L IE792462 L IE 792462L IE 792462 A IE792462 A IE 792462A IE 246279 A IE246279 A IE 246279A IE 792462 L IE792462 L IE 792462L
Authority
IE
Ireland
Prior art keywords
compounds
formula
protective group
azetidinones
ch643265a5
Prior art date
Application number
IE792462A
Other versions
IE49876B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to IE2246/85A priority Critical patent/IE49877B1/en
Publication of IE792462L publication Critical patent/IE792462L/en
Publication of IE49876B1 publication Critical patent/IE49876B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Penem compounds of the formula I are described. The definitions of the substituents X, Y and Z can be taken from Patent Claim 1. They can be obtained by cyclisation of compounds of the formula II in which R<''> is an ester protective group, followed by removal of this protective group in cases where Z denotes hydrogen. The compounds have a good activity as antibacterial agents. <IMAGE> [CH643265A5]
IE2462/79A 1978-12-18 1979-12-18 Azetidinones IE49876B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE2246/85A IE49877B1 (en) 1978-12-18 1979-12-18 Penems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96866378A 1978-12-18 1978-12-18

Publications (2)

Publication Number Publication Date
IE792462L true IE792462L (en) 1980-06-18
IE49876B1 IE49876B1 (en) 1986-01-08

Family

ID=25514601

Family Applications (3)

Application Number Title Priority Date Filing Date
IE2246/85A IE49877B1 (en) 1978-12-18 1979-12-18 Penems
IE2462/79A IE49876B1 (en) 1978-12-18 1979-12-18 Azetidinones
IE1853/85A IE50597B1 (en) 1978-12-18 1979-12-18 Azetidinones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IE2246/85A IE49877B1 (en) 1978-12-18 1979-12-18 Penems

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE1853/85A IE50597B1 (en) 1978-12-18 1979-12-18 Azetidinones

Country Status (13)

Country Link
JP (1) JPS60222486A (en)
AU (4) AU541717B2 (en)
CA (2) CA1286661C (en)
CH (2) CH643265A5 (en)
DK (5) DK533879A (en)
ES (1) ES8101594A1 (en)
FI (2) FI67853C (en)
GR (2) GR81420B (en)
IE (3) IE49877B1 (en)
IL (2) IL58576A (en)
SE (5) SE448995B (en)
YU (4) YU43628B (en)
ZA (2) ZA796813B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8509180D0 (en) * 1985-04-10 1985-05-15 Erba Farmitalia Penem derivatives
US4826832A (en) * 1986-05-06 1989-05-02 Ciba-Geigy Corporation Penen compounds
WO1996025417A1 (en) * 1995-02-17 1996-08-22 Suntory Limited Penem derivatives and antimicrobial agent containing the same
US6365635B1 (en) 1998-01-13 2002-04-02 Suntory Limited Antibacterial composition for topical administration containing antibiotic
JP2005239696A (en) 2004-01-30 2005-09-08 Daiichi Suntory Pharma Co Ltd Medicinal hard capsule preparation blended with inorganic substance
CN112746066B (en) * 2021-01-25 2023-10-31 洛阳华荣生物技术有限公司 L-lysine decarboxylase mutant and application thereof

Also Published As

Publication number Publication date
AU3240884A (en) 1984-12-13
AU557545B2 (en) 1986-12-24
ES487034A0 (en) 1980-12-16
FI69845C (en) 1986-05-26
AU541717B2 (en) 1985-01-17
SE8405813L (en) 1984-11-19
YU43280B (en) 1989-06-30
FI69845B (en) 1985-12-31
SE7910391L (en) 1981-06-18
DK161520B (en) 1991-07-15
IL58576A (en) 1985-12-31
YU215782A (en) 1983-06-30
AU5371079A (en) 1980-06-26
AU3288484A (en) 1985-03-07
JPS60222486A (en) 1985-11-07
DK135291D0 (en) 1991-07-15
DK161520C (en) 1991-12-23
IE49876B1 (en) 1986-01-08
FI67853B (en) 1985-02-28
AU539983B2 (en) 1984-10-25
SE8405812D0 (en) 1984-11-19
SE454779B (en) 1988-05-30
SE448995B (en) 1987-03-30
IL58804A (en) 1986-03-31
DK237690A (en) 1990-10-01
FI793903A (en) 1980-06-19
GR81420B (en) 1984-12-11
AU563015B2 (en) 1987-06-25
DK161970C (en) 1992-02-03
DK236590A (en) 1990-10-01
YU215382A (en) 1983-06-30
SE8405812L (en) 1984-11-19
DK135291A (en) 1991-07-15
CA1268183A (en) 1990-04-24
SE461395B (en) 1990-02-12
SE8405719D0 (en) 1984-11-14
ES8101594A1 (en) 1980-12-16
IE49877B1 (en) 1986-01-08
YU43628B (en) 1989-10-31
SE8405813D0 (en) 1984-11-19
IE852246L (en) 1980-06-18
DK237690D0 (en) 1990-10-01
FI793905A (en) 1980-06-19
SE8405719L (en) 1984-11-14
YU276079A (en) 1983-02-28
YU42125B (en) 1988-04-30
SE7910390L (en) 1981-06-18
IE50597B1 (en) 1986-05-28
ZA796813B (en) 1981-05-27
YU43464B (en) 1989-08-31
GR74491B (en) 1984-06-28
ZA796812B (en) 1981-05-27
CH643846A5 (en) 1984-06-29
IL58576A0 (en) 1980-01-31
AU5378779A (en) 1980-08-28
DK161970B (en) 1991-09-02
DK236590D0 (en) 1990-10-01
SE464027B (en) 1991-02-25
FI67853C (en) 1985-06-10
IE851853L (en) 1980-06-18
IL58804A0 (en) 1980-02-29
DK533879A (en) 1980-06-19
DK533779A (en) 1980-06-19
YU307679A (en) 1983-02-28
CA1286661C (en) 1991-07-23
CH643265A5 (en) 1984-05-30

Similar Documents

Publication Publication Date Title
IE791967L (en) Cyclosporin derivatives
AU5246596A (en) Compounds as intermediates
IE801007L (en) Penicillins
IE791895L (en) Alkanoyl prolines.
AU513636B2 (en) Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IE822026L (en) Imidazotetrazinones
ES479166A1 (en) Process for the preparation of 7 alpha -methoxy-7 beta -(1,3-diethietane-2-carboxyamido)cephalosporanic acid derivatives
IE812859L (en) Azetidinones.
ES8502708A1 (en) Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics.
ES8707244A1 (en) 6-Alkylidene penems, their preparation and use, and intermediates.
IE851853L (en) Azetidinones.
AU544923B2 (en) Peptides
EP0192783A4 (en) 2-piperazinopyrimidine derivatives and process for their preparation.
IE791943L (en) Phenyl quinolizidines.
IE823087L (en) Azetidinones.
ES8104323A1 (en) Production of 2,6-diaminonebularines.
IE780198L (en) Oxadiazolopyrimidine derivatives
ES8304085A1 (en) Oxime esters, processes for their preparation, their use and compositions containing these esters.
IE811601L (en) Pentapeptides
IE820342L (en) Penicillins
CA2092919A1 (en) Epoxysuccinamic acid derivatives
IE791930L (en) Cyclohexadienes.
MX9700003A (en) Process for the preparation of chloromethyl-phenylglyoxylic acid derivatives.
IE790650L (en) Substituted n-iminomethylpiperidine
AU525735B2 (en) Diuretic composition